Meet the Program Founder
Dr. Nuran Kumbaraci is the founder of the Chemical Biology program. Her research is focused on applying chemical and biochemical methods to determine the mechanism of diseases and develop biomarkers for…
Chemical Biology Master's Program
Gain highly valued research skills from the first chemical biology program in the nation.
The chemical biology master’s program at Stevens gives you unparalleled preparation for a range of satisfying careers in research, medicine and industry. Our program is the first chemical biology program founded in the U.S. Our historical presence in the field serves our students well, both while they are here at Stevens and beyond graduation.
Along with advanced theoretical studies, you’ll pursue original research in world-class laboratories under the mentorship of leading experts in the field.
The Stevens Advantage
You’ll acquire the in-depth lab experience that top employers look for and make connections in pharma, medicine and academia that will help you thrive. We’re also just 15 minutes from downtown Manhattan and situated in the center of the New Jersey pharmaceutical corridor near companies looking for top talent.
Faculty Profile
Stevens’ World-Class Faculty
Stevens’ faculty members have gained international recognition through their research and bring real-world experience to their teaching thanks to affiliations with industry-leading pharmaceutical companies…
Abhishek Sharma
Abhishek Sharma is at the forefront in developing next generation anti cancer agents to treat breast cancer, funded by the Komen Foundation.
Marcin Iwanicki
Marcin Iwanicki studies the mechanisms of ovarian cancer initiation and progression with novel techniques such as CRISPR/CAS9 gene editing.
Peter Tolias
Peter Tolias leads groundbreaking discovery and translational development of drugs, biomarkers and clinical technologies.
James Liang
James Liang develops cutting-edge implantable devices and drug delivery systems for biomedical applications.
Meet Outstanding Speakers
Stivala Lectures in Chemistry Series
The department invites an outstanding scientist for a day of lectures and discussions on timely topics in chemistry. The BCB department also hosts a preeminent scientist for a sequence of informal talks and formal lectures. Previous lecturers have included Kenneth Pitzer and Herman Mark and the Nobelists William Lipscomb, Sir Derek Barton, Ilya Prigogine, Arthur Kornberg, Rosalyn Yalow, Sidney Altman and George Palade.
Resources for Your Ideas & Research
Some of the major advantages of studying chemical biology at a premier research institution like Stevens include support for your ideas, great mentors, industry connections and the best tools for your research.
Center for Healthcare Innovation
Supports student-initiated research to advance biomedical technology and healthcare delivery, including cancer biology and tissue engineering.
Tolias Lab
Dr. Peter Tolias leads multidisciplinary research efforts in personalized medicine, including projects focus on patient-specific genomic analysis of disease.
Center for Mass Spectrometry
One of the most well-equipped academic facilities in the U.S., the Center’s aim is to provide the most frontier-level research programs.
Sharma Lab
The Sharma Lab's goal is to develop novel-molecular reactivity and molecular function to accelerate the discovery of new therapeutics.
Zhang Lab
With support from NIH and NSF, the Lab works to obtain structural and mechanistic information on small signaling molecules.
Liang Lab
This lab's research includes bacteria responsive materials for medical device infections and nanotechnology enabled cancer cell sensing.
Department Labs
CCB is home to more than a dozen laboratories equipped with state-of-the-art instrumentations for student use.
Chemical Biology Research at Stevens
Stevens is a Premier Research Institution
At Stevens, you have the opportunity to work directly with our renowned faculty members researching groundbreaking topics such as the design and synthesis of medicinally important phenolic and heterocyclic compounds; novel ERK inhibitors; and fabrication of hollow tubular scaffolds for blood vessel-like structure formation.